Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
BCL-2 inhibitors are an important treatment class in Chronic lymphocytic leukemia (CLL) / Small lymphocytic lymphoma (SLL), and in practice this mainly means venetoclax, the first established BCL-2 inhibitor for these diseases. Venetoclax is FDA-approved for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, either alone or in combination regimens depending on the setting
…